NCT05623267: Sugemalimab as Consolidation Therapy in Patients With LS-SCLC Following cCRT or sCRT
- State
- Under way
- Phase
- Phase 2 and Phase 3
- People
- 346 planned
- Started
- 1 Jul 2023
- Primary completion
- 31 Dec 2025
- Arms
- Experimental arm
- Results
- None posted
- 21 Nov 2022: Trial registered
- 1 Jul 2023: Trial started